Patents by Inventor Aldo Iacono

Aldo Iacono has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)
    Publication number: 20230364182
    Abstract: The present invention relates to a composition comprising cyclosporine A (CsA) for use in the prevention of bronchiolitis obliterans syndrome (BOS) in a double lung transplanted patient, or for the treatment of BOS or for the prevention or delay of the progression of BOS in a double lung transplanted patient being diagnosed with BOS, wherein the composition is administered to said patient by inhalation of said composition in aerosolized form comprising a therapeutically effective dose of cyclo- sporine A.
    Type: Application
    Filed: May 23, 2023
    Publication date: November 16, 2023
    Inventors: Aldo Iacono, Oliver Denk, Gerhard Boerner
  • Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)
    Patent number: 11701403
    Abstract: The present invention relates to a composition comprising cyclosporine A (CsA) for use in the prevention of bronchiolitis obliterans syndrome (BOS) in a double lung transplanted patient, or for the treatment of BOS or for the prevention or delay of the progression of BOS in a double lung transplanted patient being diagnosed with BOS, wherein the composition is administered to said patient by inhalation of said composition in aerosolized form comprising a therapeutically effective dose of cyclo-sporine A.
    Type: Grant
    Filed: September 26, 2022
    Date of Patent: July 18, 2023
    Inventors: Aldo Iacono, Oliver Denk, Gerhard Boerner
  • Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)
    Publication number: 20230128855
    Abstract: The present invention relates to a composition comprising cyclosporine A (CsA) for use in the prevention of bronchiolitis obliterans syndrome (BOS) in a double lung transplanted patient, or for the treatment of BOS or for the prevention or delay of the progression of BOS in a double lung transplanted patient being diagnosed with BOS, wherein the composition is administered to said patient by inhalation of said composition in aerosolized form comprising a therapeutically effective dose of cyclosporine A.
    Type: Application
    Filed: September 26, 2022
    Publication date: April 27, 2023
    Inventors: Aldo Iacono, Oiver Denk, Gerhard Boerner
  • Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)
    Patent number: 11484566
    Abstract: The present invention relates to a composition comprising cyclosporine A (CsA) for use in the prevention of bronchiolitis obliterans syndrome (BOS) in a double lung transplanted patient, or for the treatment of BOS or for the prevention or delay of the progression of BOS in a double lung transplanted patient being diagnosed with BOS, wherein the composition is administered to said patient by inhalation of said composition in aerosolized form comprising a therapeutically effective dose of cyclosporine A.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: November 1, 2022
    Inventors: Aldo Iacono, Oliver Denk, Gerhard Boerner